JSPR - Multiplikator forward rega marang pendapatan jaspertherapeutics.com

Jasper Therapeutics' high scientific potential in developing antibodies for bone marrow clearance relies on strict adherence to biosafety standards. The firm's forward P/S reflects the market valuation trend, where the current level is . Unique toxicity reduction methods during transplantation provide the company with exceptional pricing power over its drugs.

Jasper Therapeutics, Inc. - Prakiraan rega marang pendapatan JSPR (periode 04.07.2022 - 14.11.2026)

jaspertherapeutics.com - rincian analitis lan metrik utama (JSPR)

- rega pasar lan target rega analis:

Bagan rega Jasper Therapeutics, Inc.|JSPR - Bagan rega target

- statistik kapitalisasi pasar:

Biji pasar JSPR|JSPR - Nilai Dipunlarasaken Utang lan Kas

- rincian valuasi buku bisnis:

Nilai Buku saben Saham Jasper Therapeutics|JSPR - Nilai Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku jaspertherapeutics.com|JSPR - Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Utang marang Ekuitas Jasper Therapeutics|JSPR - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Jasper Therapeutics, Inc.|JSPR - Utang kumulatif perusahaan|Utang marang nilai buku JSPR|JSPR - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Jasper Therapeutics|Rasio cepet jaspertherapeutics.com

- rincian asil keuangan lan kelipatan valuasi:

JSPR - Bathi pungkasan|Proyeksi bathi mangsa ngarep Jasper Therapeutics|JSPR - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Jasper Therapeutics, Inc.|JSPR - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA JSPR|JSPR - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Jasper Therapeutics|JSPR - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan jaspertherapeutics.com|JSPR - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Jasper Therapeutics

- data pendapatan lan penerimaan dodolan:

JSPR - Total dodolan perusahaan|Prakiraan volume dodolan Jasper Therapeutics, Inc.|JSPR - Multiplikator P/S|Rasio rega marang prakiraan pendapatan JSPR

Analisis wiwitan perusahaan:Jasper Bio (JSPR)

The steady hiring of leading immunologists and the expansion of clinical trials at Jasper Therapeutics (JSPR) are reflected in the forward P/S ratio dynamics, confirming market expectations for business growth. This indicator compares the company's current market value with its expected revenues, allowing investors to assess the premium paid for future sales and determine the fair value of assets in the absence of current earnings.

Pesaing wigati

Rasio rega marang prakiraan pendapatan Legend Biotech Corporation LEGN|Sana Biotechnology Inc - Rasio rega marang prakiraan pendapatan|AUTL: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ALLO (Allogene Corp)|RNAC: Multiplikator Forward P/S|Prakiraan rega marang pendapatan Cellectis CLLS|CRBU (Caribou Biosciences, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Instil Bio Inc. TIL|Rasio rega marang prakiraan pendapatan Genenta Science S.p.A. (GNTA)|centurytx.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S SNTI (Senti Biosciences)|Adaptimmune Therapeutics plc (ADAP) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|CERO: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan TCRT (Alaunos Therapeutics)|ACHL (achillestx.com) - Multiplikator forward rega marang pendapatan|CRGX: Rasio rega marang pendapatan sing dikarepake|PSTX (Poseida Therapeutics) - Multiplikator Forward P/S|TSVT: Rega forward marang dodolan|Multiplikator Forward P/S GRCL